Cellular and biochemical mechanisms of the resistance of human cancer cells to a new anticancer ribo-nucleoside, TAS-106. (Q40734918)

1 July 2018

title

Cellular and biochemical mechanisms of the resistance of human cancer cells to a new anticancer ribo-nucleoside, TAS-106. (English)

1 reference

1 July 2018

author name string

Yuji Shimamoto

1

1 reference

1 July 2018

Hiromi Kazuno

2

1 reference

1 July 2018

Yuko Murakami

3

1 reference

1 July 2018

Atsushi Azuma

4

1 reference

1 July 2018

Katsuhisa Koizumi

5

1 reference

1 July 2018

Akira Matsuda

6

1 reference

1 July 2018

Takuma Sasaki

7

1 reference

1 July 2018

Masakazu Fukushima

8

1 reference

1 July 2018

publication date

1 April 2002

1 reference

1 July 2018

number of pages

8

1 reference

Japanese Journal of Cancer Research

inferred from page(s)

published in

1 reference

1 July 2018

volume

93

1 reference

1 July 2018

issue

4

1 reference

1 July 2018

page(s)

445-452

1 reference

1 July 2018

Development and molecular characterization of a 2',2'-difluorodeoxycytidine-resistant variant of the human ovarian carcinoma cell line A2780.

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5927010

Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing.

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5927010

Evaluation of the antitumor activity of gemcitabine (2',2'-difluoro-2'-deoxycytidine).

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5927010

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5927010

Antitumor activity and pharmacokinetics of TAS-106, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5927010

Nucleosides and nucleotides. 158. 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)-cytosine, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)uracil, and their nucleobase analogues as new potential multifunctional antitumor nucleosides with a broad spectrum of a

19 August 2018

1 reference

12 December 2020

Antitumor effect of a novel multifunctional antitumor nucleoside, 3'-ethynylcytidine, on human cancers

1 reference

12 December 2020

The analysis of the innate pathways of 5-fluorouracil phosphorylation in human gastrointestinal cancer cell lines in vitro and in vivo

1 reference

12 December 2020

Anti-tumor mechanisms of 3'-ethynyluridine and 3'-ethynylcytidine as RNA synthesis inhibitors: development and characterization of 3'-ethynyluridine-resistant cells

1 reference

12 December 2020

Comparison of the toxicity and metabolism of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 9-beta-D-arabinofuranosyladenine in human lymphoblastoid cells

1 reference

12 December 2020

Metabolism of pyrimidine nucleotides in various tissues and tumor cells from rodents

1 reference

12 December 2020

A new antitumor nucleoside, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd), is a potent inhibitor of RNA synthesis

1 reference

12 December 2020

Comparison of the cellular pharmacokinetics and toxicity of 2',2'-difluorodeoxycytidine and 1-beta-D-arabinofuranosylcytosine

1 reference

12 December 2020

Antitumor mechanisms and metabolism of the novel antitumor nucleoside analogues, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine and 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)uracil

1 reference

12 December 2020

10.1111/J.1349-7006.2002.TB01276.X

Identifiers

DOI

1 reference

1 July 2018

PMC publication ID

5927010

1 reference

1 July 2018

PubMed publication ID

11985795

1 reference

1 July 2018